JP Morgan Private Wealth Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $354K | Sell |
|
|||||
|
2023
Q2 | $391K | Sell |
|
|||||
|
2023
Q1 | $541K | Sell |
|
|||||
|
2022
Q4 | $566K | Sell |
|
|||||
|
2022
Q3 | $593K | Sell |
|
|||||
|
2022
Q2 | $545K | Sell |
|
|||||
|
2022
Q1 | $622K | Sell |
|
|||||
|
2021
Q4 | $659K | Buy |
|
|||||
|
2021
Q3 | $569K | Buy |
|
|||||
|
2021
Q2 | $648K | Buy |
|
|||||
|
2021
Q1 | $550K | Buy |
|
|||||
|
2020
Q4 | $472K | Sell |
|
|||||
|
2020
Q3 | $475K | Buy |
|
|||||
|
2020
Q2 | $518K | Buy |
|
|||||
|
2020
Q1 | $321K | Buy |
|
|||||
|
2019
Q4 | $339K | Sell |
|
|||||
|
2019
Q3 | $414K | Buy |
|
|||||
|
2019
Q2 | $328K | Sell |
|
|||||
|
2019
Q1 | $357K | Sell |
|
|||||
|
2018
Q4 | $339K | Sell |
|
|||||
|
2018
Q3 | $539K | Sell |
|
|||||
|
2018
Q2 | $753K | Buy |
|
|||||
|
2018
Q1 | $522K | Buy |
|
|||||
|
2017
Q4 | $428K | Sell |
|
|||||
|
2017
Q3 | $437K | Buy |
|
|||||
|
2017
Q2 | $419K | Buy |
|
|||||
|
2017
Q1 | $274K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $162K | Buy |
|